Cargando…
Advances in the conventional clinical treatment for hepatoblastoma and therapeutic innovation
BACKGROUND: Hepatoblastoma (HB) is a rare malignancy usually occurring in children under 3 years old. With advancements in surgical techniques and molecular biology, new treatments have been developed. DATA RESOURCES: The recent literatures on new treatments, molecular mechanisms and clinical trials...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716786/ https://www.ncbi.nlm.nih.gov/pubmed/36474976 http://dx.doi.org/10.1136/wjps-2020-000220 |